The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Agile Therapeutics Inc. | COM | 00847L209 | 103 | 87,754 | SH | SOLE | 87,754 | 0 | 0 | ||
| Citigroup Inc | COM NEW | 172967424 | 460 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| NASDAQ Inc | COM | 631103108 | 2,958,382 | 19,394,142 | SH | SOLE | 19,394,142 | 0 | 0 | ||
| Stanley Black & Decker Inc | COM | 854502101 | 325 | 3,100 | SH | SOLE | 3,100 | 0 | 0 | ||
| WeWork Inc | CL A | 96209A104 | 1,140 | 227,139 | SH | SOLE | 227,139 | 0 | 0 | ||